Inthera Bioscience
Schlieren
About Inthera Bioscience
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2018)
- Website: intherabio.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inthera-bioscience-117032 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.